Advanced search
Publication Cover
Statistics in Biopharmaceutical Research Volume 8, 2016 - Issue 3: Papers from the 2015 ASA Biopharmaceutical Section Statistics Workshop
Submit an article Journal homepage
230
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

A Meta-Analysis of Missing Data and Non-Compliance Data in Clinical Endpoint Bioequivalence Studies

Wanjie SunOffice of Biostatistics, Center for Drug Evaluation and Research, Food and Drug Administration (CDER/FDA), Silver Spring, MD, USACorrespondence[email protected]
,
Lingjie ZhouDepartment of Statistics, George Washington University, Washington, DC, USA
,
Stella GrosserOffice of Biostatistics, Center for Drug Evaluation and Research, Food and Drug Administration (CDER/FDA), Silver Spring, MD, USA
&
Carol KimOffice of Generic Drugs, CDER/FDA, Silver Spring, MD, USA
Pages 334-344 | Received 01 Sep 2015, Published online: 16 Sep 2016

References

  • Cochran, W. G. (1954), “The Combination of Estimates from Different Experiments,” Biometrics, 10, 101–129.
  • Davit, B. M., Nwakama, P. E., Buehler, G. J., Conner, D. P., Haidar, S. H., Patel, D. T., Yang, Y., Lawrence, Y., and Woodcock, J. (2009), “Comparing Generic and Innovator Drugs: A Review of 12 Years of Bioequivalence Data from the United States Food and Drug Administration,” The Annals of Pharmacotherapy, 43, 1583–1597.
  • Fieller, E. C. (1940), “The Biological Standardization of Insulin,” Supplement to the Journal of the Royal Statistical Society, 7, 1–64.
  • ——— (1954), “Some Problems in Interval Estimation,” Journal of the Royal Statistical Society, Series B 16, 175–185.
  • Heyting, A., Tolboom, J. T. B. M., and Essers, J. G. A. (1992), “Statistical Handling of Drop‐Outs in Longitudinal Clinical Trials,” Statistics in Medicine, 11, 2043–2061.
  • Jaeger, M. (2006), “On Testing the Missing at Random Assumption,” in Machine Learning: ECML, Springer Berlin Heidelberg, pp. 671–678.
  • LaVange, L. M., and Permutt, T. (2015), “A Regulatory Perspective on Missing Data in the Aftermath of the NRC Report,” Statistics in Medicine, 17 Dec 2015 published online. DOI: 10.1002/sim.6840.
  • Little, R. J. (1993), “Pattern-Mixture Models for Multivariate Incomplete Data,” Journal of American Statistician Association, 88, 125–134.
  • Little, R. J., D'Agostino, R., Cohen, M. L., Dickersin, K., Emerson, S. S., Farrar, J. T., Frangakis, C., Hogan, J. W., Molenberghs, G., Murphy, S. A., and Neaton, J. D. (2012), “The Prevention and Treatment of Missing Data in Clinical Trials,” New England Journal of Medicine, 367, 1355–1360.
  • Little, R. J., and Rubin, D. B. (2002), Statistical Analysis With Missing Data (2nd ed.), Hoboken, NJ: Wiley.
  • Panel on Handling Missing Data in Clinical Trials; National Research Council CNSTAT & DBASSE. (2010), The Prevention and Treatment of Missing Data in Clinical Trials, Washington, DC: The National Academies Press.
  • Permutt, T. (2015a), “A Taxonomy of Estimands for Regulatory Clinical Trials With Discontinuations,” Statistics in Medicine. 17 Dec 2015 published online. DOI: 10.1002/sim.6841.
  • ——— (2015b), “Sensitivity Analysis for Missing Data in Regulatory Submissions,” Statistics in Medicine. 15 Dec 2015 published online. DOI: 10.1002/sim.6753.
  • Rubin, D. B. (1976), “Inference and Missing Data,” Biometrika, 63, 581–592.
  • Schuirmann, D. (1987), “A Comparison of the Two One-Sided Tests Procedure and the Power Approach for Assessing the Equivalence of Average Bioavailability,” Journal of Pharmacokinetics and Biopharmaceutics, 15, 657–680.
  • Whitehead, A. (2002), Meta-Analysis of Controlled Clinical Trials (1st ed.), Hoboken, NJ: Wiley.
  • Whitehead, A., and Whitehead, J. (1991), “A General Parametric Approach to the Meta‐Analysis of Randomized Clinical Trials,” Statistics in Medicine, 10, 1665–1677.
  • Yu, Li. (2014), FDA Bioequivalence Standards, New York: Springer. 248–250.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.